170 related articles for article (PubMed ID: 28179883)
1. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.
López-Riera M; Conde I; Tolosa L; Zaragoza Á; Castell JV; Gómez-Lechón MJ; Jover R
Front Pharmacol; 2017; 8():3. PubMed ID: 28179883
[No Abstract] [Full Text] [Related]
2. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.
Johnson K; Leary PJ; Govaere O; Barter MJ; Charlton SH; Cockell SJ; Tiniakos D; Zatorska M; Bedossa P; Brosnan MJ; Cobbold JF; Ekstedt M; Aithal GP; Clément K; Schattenberg JM; Boursier J; Ratziu V; Bugianesi E; Anstee QM; Daly AK; ;
JHEP Rep; 2022 Feb; 4(2):100409. PubMed ID: 35072021
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat.
Quintás G; Caiment F; Rienda I; Pérez-Rojas J; Pareja E; Castell JV; Jover R
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012565
[TBL] [Abstract][Full Text] [Related]
4. Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis.
Vulf M; Shunkina D; Komar A; Bograya M; Zatolokin P; Kirienkova E; Gazatova N; Kozlov I; Litvinova L
Front Cell Dev Biol; 2021; 9():736677. PubMed ID: 34568346
[TBL] [Abstract][Full Text] [Related]
5. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades.
Liu Z; Wang Y; Borlak J; Tong W
Sci Rep; 2016 Apr; 6():23709. PubMed ID: 27045805
[TBL] [Abstract][Full Text] [Related]
6. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression.
Gim JA; Bang SM; Lee YS; Lee Y; Yim SY; Jung YK; Kim H; Kim BH; Kim JH; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS
PLoS One; 2021; 16(8):e0255822. PubMed ID: 34358264
[TBL] [Abstract][Full Text] [Related]
9. Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis.
Díez-Sainz E; Aranaz P; Amri EZ; Riezu-Boj JI; Lorente-Cebrián S; Milagro FI
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338999
[TBL] [Abstract][Full Text] [Related]
10. Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.
Ando Y; Yamazaki M; Yamada H; Munetsuna E; Fujii R; Mizuno G; Ichino N; Osakabe K; Sugimoto K; Ishikawa H; Ohashi K; Teradaira R; Ohta Y; Hamajima N; Hashimoto S; Suzuki K
Sci Rep; 2019 Dec; 9(1):18856. PubMed ID: 31827150
[TBL] [Abstract][Full Text] [Related]
11. The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis.
Lambrecht J; Verhulst S; Reynaert H; van Grunsven LA
Cells; 2019 Aug; 8(9):. PubMed ID: 31470644
[No Abstract] [Full Text] [Related]
12. Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis.
Lin H; Mercer KE; Ou X; Mansfield K; Buchmann R; Børsheim E; Tas E
Front Endocrinol (Lausanne); 2022; 13():856973. PubMed ID: 35498403
[TBL] [Abstract][Full Text] [Related]
13. Reverse Expression of Aging-Associated Molecules through Transfection of miRNAs to Aged Mice.
Kim JH; Lee BR; Choi ES; Lee KM; Choi SK; Cho JH; Jeon WB; Kim E
Mol Ther Nucleic Acids; 2017 Mar; 6():106-115. PubMed ID: 28325277
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
Erhartova D; Cahova M; Dankova H; Heczkova M; Mikova I; Sticova E; Spicak J; Seda O; Trunecka P
PLoS One; 2019; 14(11):e0224820. PubMed ID: 31703079
[TBL] [Abstract][Full Text] [Related]
15. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review.
Sun Y; Shen Y; Liang X; Zheng H; Zhang Y
Clin Ther; 2023 Mar; 45(3):234-247. PubMed ID: 36841739
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease.
Miyaaki H; Ichikawa T; Kamo Y; Taura N; Honda T; Shibata H; Milazzo M; Fornari F; Gramantieri L; Bolondi L; Nakao K
Liver Int; 2014 Aug; 34(7):e302-7. PubMed ID: 24313922
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Repression of CYP3A4 by Increased miR-200a-3p and miR-150-5p Promotes Steatosis
Huang Z; Wang M; Liu L; Peng J; Guo C; Chen X; Huang L; Tan J; Yang G
Front Genet; 2019; 10():484. PubMed ID: 31191607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
